Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Dear Colleague Letter: Posttranscriptional and Posttranslational Modification (PPM)

National Science Foundation

May 02, 2024

Dear Colleagues:

Presidential Executive Order (EO) 14081 on "Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe and Secure American Bioeconomy" envisions a vital role for biotechnology in harnessing the power of biology to benefit society. From mitigating climate change to ensuring food security, improving human health, and creating resilient supply chains, understanding the mechanisms in cells and organisms that shape how genotype becomes phenotype, and how cellular information is transformed into organismal fitness and performance is central to achieving breakthroughs in biotechnology and growing the bioeconomy. The central dogma of molecular biology has expanded well beyond the flow of information from DNA-to-RNA-to-protein into a system of complex interactions and feedback loops among all these macromolecules and, importantly, their many isoforms and chemically modified variants. Post-transcriptional RNA modifications (PRM) and post-translational protein modifications (PTM) are essential mechanisms used by cells to diversify and regulate the structure and function of RNA and proteins, and to coordinate regulatory and signaling networks. Beyond post-transcriptional and post-translational processing, such as RNA splicing or signal peptide cleavage, the many, possible combinations of covalent PRM and PTM modifications provide a critical mechanism for defining, as well as modulating, cellular and organismal states and functions, and numerous developmental and physiological disorders have been linked to defects in PRM and PTM pathways. The challenge now is to understand how these modifications interact with one another and create multi-layered, dynamic, regulatory networks within cells, that govern organismal phenotype .

The chemical properties of RNA enable a large diversity of structures and roles in biological systems, from coding information to scaffolding to catalysis. This broad palette is further enhanced through site-specific addition of over 170 currently known PRMs. These covalent modifications are found in all major RNA classes (tRNA, mRNA and rRNA) across all three domains of life (archaea, bacteria and eukaryotes), as well as in small RNAs (e.g., miRNA and snRNA) and long noncoding RNAs. In addition to questions about modification mechanisms and impacts on RNA structure and function, how multiple modifications influence each other on the same or different RNAs, why the same modification can have different effects on different classes of RNA (e.g., miRNA vs. tRNA), how these PRM affect RNA interactions with proteins and DNA, and ultimately how they define cellular and organismal functions all remain largely unexplored.

Likewise, PTMs extend the chemical repertoire of the 20 standard amino acids by over 400 known covalent modifications. PTMs influence all aspects of protein structure and function and, thus, cellular and organismal biology. While modifications of a few protein classes, such as kinases and histones, have been studied extensively, much less is understood about the PTMs of many other proteins. Moreover, how multiple modifications on individual proteins interact to impact assembly, structure and function of complexes and proteomes is also largely unexplored. Finally, how modified RNAs and proteins work together also remains fertile ground for investigation.

With this Dear Colleague Letter (DCL), NSF invites proposals that address understanding how multiple modifications of single or multiple, functionally-related RNAs and/or proteins influence the properties, interactions, and/or regulation of these macromolecules, and ultimately their role in cellular and organismal phenotype.

Proposals must follow the guidelines and any solicitation specific criteria, if applicable, of the relevant NSF program most closely related to the research. The title of a proposal submitted in response to this DCL must begin with "PPM" after any solicitation-specific title requirements, if applicable. The participating programs are:

Proposals submitted in response to this DCL will be reviewed alongside other proposals submitted to the relevant program, and will be reviewed in accordance with NSF's review criteria for Intellectual Merit and Broader Impacts and any solicitation specific review criteria, if applicable.

Specialties

Engineering and Physical Sciences

Interdisciplinary

Medical - Basic Science

Environmental & Life Sciences

Medical

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: National Science Foundation

Sponsor Type:

Address: National Science Foundation Alexandria, VA 22314

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity